1239TiPMORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types. (23rd October 2018) - Chau, I; Haag, G M; Rahma, O E; Macarulla, T M; McCune, S L; Yardley, D A; Solomon, B J; Johnson, M; Vidal, G A; Schmid, P; Argiles, G; Dimick, K; et al.